AR124877A1 - Composiciones orales sólidas con zinc - Google Patents

Composiciones orales sólidas con zinc

Info

Publication number
AR124877A1
AR124877A1 ARP220100298A ARP220100298A AR124877A1 AR 124877 A1 AR124877 A1 AR 124877A1 AR P220100298 A ARP220100298 A AR P220100298A AR P220100298 A ARP220100298 A AR P220100298A AR 124877 A1 AR124877 A1 AR 124877A1
Authority
AR
Argentina
Prior art keywords
zinc
solid oral
oral compositions
payload
carrier
Prior art date
Application number
ARP220100298A
Other languages
English (en)
Inventor
Derek Maclean
Charles Olson
Michael Sekar
Ezhil Amirthalingam
Original Assignee
Applied Molecular Transport Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Applied Molecular Transport Inc filed Critical Applied Molecular Transport Inc
Publication of AR124877A1 publication Critical patent/AR124877A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/28—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Vibrionaceae (F)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/52—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an inorganic compound, e.g. an inorganic ion that is complexed with the active ingredient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
    • A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
    • A61K47/6415—Toxins or lectins, e.g. clostridial toxins or Pseudomonas exotoxins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/55—Fusion polypeptide containing a fusion with a toxin, e.g. diphteria toxin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Zoology (AREA)
  • Inorganic Chemistry (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)

Abstract

La presente descripción proporciona una composición que comprende una carga útil, un portador asociado con la carga útil, en donde el portador es capaz de facilitar la transcitosis del portador y la carga útil a través de una célula epitelial polarizada; y un ion zinc.
ARP220100298A 2021-02-16 2022-02-15 Composiciones orales sólidas con zinc AR124877A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US202163150078P 2021-02-16 2021-02-16

Publications (1)

Publication Number Publication Date
AR124877A1 true AR124877A1 (es) 2023-05-17

Family

ID=82931137

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP220100298A AR124877A1 (es) 2021-02-16 2022-02-15 Composiciones orales sólidas con zinc

Country Status (3)

Country Link
AR (1) AR124877A1 (es)
TW (1) TW202245842A (es)
WO (1) WO2022177890A1 (es)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7097845B2 (en) * 1997-04-23 2006-08-29 Jacob Sten Petersen Combinations of antigen and mucosal binding component for inducing specific immunological tolerance
US20090092660A1 (en) * 2006-08-09 2009-04-09 Trinity Biosystems, Inc. Methods and compositions for needleless delivery of particles
PT3762009T (pt) * 2018-03-08 2022-08-22 Applied Molecular Transport Inc Construções de administração derivadas de toxinas para administração oral
CN113347997A (zh) * 2018-11-07 2021-09-03 应用分子运输公司 用于经口递送异源有效载荷的Cholix衍生的携带体
BR112022002975A2 (pt) * 2019-08-16 2022-06-28 Applied Molecular Transport Inc Composições e partículas para aplicação de carga útil

Also Published As

Publication number Publication date
WO2022177890A1 (en) 2022-08-25
TW202245842A (zh) 2022-12-01

Similar Documents

Publication Publication Date Title
TWD201829S (zh) 無柵線太陽能電池
WO2019083327A3 (ko) 헤테로고리 화합물을 이용한 유기 발광 소자
CR20190591A (es) Cubetas de lectura
TWD208657S (zh) 收納盒(一)
GB2563348A (en) Fabrication of correlated electron material devices comprising nitrogen
CO2018003134A2 (es) Composiciones para el cuidado bucal que comprenden un aminoácido básico, una combinación de fuentes de iones de zinc y un sistema quelante
UY36894A (es) Composiciones estables de inoculantes y métodos para producirlas
MX2020008494A (es) Nanomateriales de silicio-carbono, metodo de su elaboracion y usos.
BR112016002017A2 (pt) transistor de efeito de campo e método para produzir transistor de efeito de campo
TW200729509A (en) Semiconductor thin film, the making method and the thin film transistor
TWD201823S (zh) 太陽能電池
TWD204202S (zh) 電池
MX2020004939A (es) Fabricacion de composiciones de celulas islote y metodos de uso de las mismas.
BR112022001416A2 (pt) Populações de células t gama delta ex vivo
PH12021551100A1 (en) Dried biological compositions and methods thereof
WO2019050100A8 (ko) 리튬 이차전지용 음극 활물질 및 그 제조방법
TWD201820S (zh) 無柵線太陽能電池
WO2019059637A3 (ko) 리튬 이차전지용 음극, 이의 제조방법 및 이를 포함하는 리튬 이차전지
MX2019013050A (es) Composiciones acondicionadoras con deposito mejorado de microcapsulas de poliacrilato.
AR124877A1 (es) Composiciones orales sólidas con zinc
MX2023001160A (es) Composicion farmaceutica del anticuerpo anti-pd-1 y uso del mismo.
WO2019059630A3 (ko) 접착제 조성물 및 이를 이용하여 형성된 접착제층을 포함하는 편광판
MX2022008983A (es) Compuesto funcional de aziridina.
BR112018070866A2 (pt) substrato de vidro refletivo azul e método de fabricação do mesmo
WO2019022514A3 (ko) 나트륨 이온 저장재료

Legal Events

Date Code Title Description
FB Suspension of granting procedure